UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2023 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction of Incor ...

ItÂ's also worth noting that our dental division continues to operate profitable. In fact, the dental division generated over $600,000 of operating income on a stand-alone basis, which is an 81% increase over the same period last year. Turning to our medical segment, we continue to advance our commercial efforts around the CompuFlo Epidural System as we target hospitals, health care systems and pain management clinics. The fact that our technology was adopted by leading physicians and hospital systems, rein ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2023 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction of Inco ...

Before we get started, we would like to remind everyone that during this conference call, we may make forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 Or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction ...

Milestone Scientific Inc. (NYSE:MLSS) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Conference Call Participants Anthony Vendetti - Maxim Group Operator Good day ladies and gentlemen and welcome to the Milestone Scientific???s Third Quarter 2022 Business Update Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after ...

Milestone Scientific Inc. (NYSE:MLSS) Q2 2022 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Arjan Haverhals - CEO Keisha Harcum - Controller David Waldman - Crescendo Communications, IR Conference Call Participants Anthony Vendetti - Maxim Group Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Milestone Scientific Second Quarter 2022 Business Update Call. At this time, all participants are in a listen-only mode. [Operator Instructions] I would ...

Milestone Scientific Inc. (NYSE:MLSS) Q1 2022 Earnings Conference Call May 17, 2022 8:30 AM ET Company Participants Arjan Haverhals - CEO Keisha Harcum - Controller David Waldman - Crescendo Communications, IR Conference Call Participants Anthony Vendetti - Maxim Group Operator Good morning, ladies and gentlemen, and welcome to the Milestone Scientific First Quarter 2022 Business Update Call. At this time, all participants have been placed on a listen-only mode, and the floor will be opened for questions an ...

Milestone Scientific Inc. (NYSE:MLSS) Q4 2021 Results Conference Call April 1, 2022 8:30 AM ET Company Participants Natalya Rudman - Crescendo Communications Arjan Haverhals - Chief Executive Officer Keisha Harcum - Controller Conference Call Participants Anthony Vendetti - Maxim Group Operator Good morning, ladies and gentlemen, and welcome to the Milestone Scientific Fiscal 2021 Year End Business Update Call. At this time, all participants have been placed in a listen-only mode and we will open the floor ...

Milestone Scientific Inc. (NYSE:MLSS) Q3 2021 Earnings Conference Call November 15, 2021 11:00 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Keisha Harcum - Controller of Milestone Scientific Conference Call Participants Anthony Vendetti - Maxim Group James Terwilliger - Northland Securities Howard Yeager - Newbridge Bill Stein - Celadon Financial Operator Good morning, ladies and gentlemen, and welcome to the Milestone Scientific Third Quarter 2021 ...